SCHEDULE: Vanguard Discloses 5.1% Stake in Inspire Medical Systems

Vanguard Capital Management reports beneficial ownership of 1,469,703 shares, representing 5.1% of Inspire Medical Systems' common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, through its affiliates, has disclosed a beneficial ownership of 1,469,703 shares of Inspire Medical Systems Inc. common stock.
• This holding represents 5.1% of the total class of securities.
• The filing indicates sole voting power over 202,965 shares and sole dispositive power over 1,469,703 shares.
• The reporting date for this ownership is March 31, 2026.
• Vanguard Capital Management is filing this statement under Rule 13d-1(b) as an investment adviser.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of institutional ownership and does not provide new operational or financial information about the company itself.

Positives

• Vanguard's significant stake suggests confidence in Inspire Medical Systems' long-term prospects.
• The filing indicates clear voting and dispositive power, suggesting a well-defined investment strategy.

Negatives

• The filing does not contain any negative financial or operational information about Inspire Medical Systems.

Risks

• As a Schedule 13G filing, it primarily reports ownership and does not detail specific risks associated with Inspire Medical Systems' business operations or the broader market.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance from Inspire Medical Systems.

Industry Context

StockSavvy.ai notes that significant institutional ownership, such as Vanguard's stake, often signals a degree of stability and potential for long-term growth, as these investors typically conduct thorough due diligence.

Stakeholder Impact

• Shareholders may view Vanguard's investment as a positive signal of institutional confidence in the company.
• The market may interpret this disclosure as a sign of stability and potential for continued institutional support.

Next Steps

• Vanguard will continue to monitor its investment in Inspire Medical Systems.
• Inspire Medical Systems will continue its business operations and financial reporting.

Key Dates

Keywords

Inspire Medical Systems, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, VGM